secwatch.observer — SEC 8-K summary
======================================

Issuer:     MASIMO CORP (MASI)
CIK:        0000937556
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0000937556-23-000063
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Masimo Q1 2023 revenue $565M (+85.7% YoY), healthcare up 14%; non-GAAP EPS $0.87 beats; FY guidance raised
--------------------------------------------------------------------------------

- Consolidated revenue $565.0M (+85.7% YoY); healthcare $346.7M (+14.0% reported, +15.8% constant currency).
- Non-healthcare (consumer) revenue $218.3M; GAAP EPS $0.39, non-GAAP EPS $0.87.
- Full-year 2023 guidance: consolidated revenue $2,415-2,460M; non-GAAP EPS $4.70-4.80.
- CEO cites solid performance, new hospital wins, and momentum in consumer health (Opioid Halo, Stork, Freedom pre-order).
- Healthcare growth driven by rainbow, Nomoline, Sedline, O3 monitoring uptake.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/937556/000093755623000063/0000937556-23-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/937556/000093755623000063/masi-20230509.htm
  HTML page:      https://secwatch.observer/filing/0000937556-23-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer